Phibro Animal Health (PAHC) Other Non-Current Assets (2013 - 2026)
Phibro Animal Health (PAHC) posted Other Non-Current Assets of $106.5 million for Q2 2026, up 6.25% on a QoQ basis from $100.2 million in Q1 2026, and up 7.01% year-over-year from $99.5 million in Q2 2025.
Analysis
Phibro Animal Health (PAHC) Other Non-Current Assets (2013 - 2026) Analysis & Trends
Phibro Animal Health has reported Other Non-Current Assets for 14 years, with the latest figure at $106.5 million in Q2 2026.
- On a quarterly basis, Other Non-Current Assets rose 7.01% year-over-year to $106.5 million in Q2 2026; TTM through Jun 2026 was $106.5 million, a 7.01% increase from a year earlier, with the FY2026 full-year figure at $106.5 million, up 7.01% from the prior year.
- Other Non-Current Assets was $106.5 million for Q2 2026 at Phibro Animal Health, up from $100.2 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $112.8 million in Q1 2025, with the low at $76.9 million in Q1 2024.
- Average Other Non-Current Assets over 5 years is $90.4 million, with a median of $85.6 million recorded in 2022.
- The largest YoY upside for Other Non-Current Assets was 46.68% in 2025 against a maximum downside of 11.32% in 2025.
- Over 5 years, Other Non-Current Assets stood at $81.7 million in 2022, then slipped by 2.56% to $79.6 million in 2023, then soared by 34.67% to $107.3 million in 2024, then retreated by 11.32% to $95.1 million in 2025, then advanced by 11.94% to $106.5 million in 2026.
- The last three Other Non-Current Assets figures came in at $106.5 million (Q2 2026), $100.2 million (Q1 2026), and $95.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 567.73 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 384.00 Mn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 304.00 Mn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 106.46 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | 31,658.00 |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | 988,922.10 |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 106.46 Mn |
| Mar 31, 2026 | 100.21 Mn |
| Dec 31, 2025 | 95.11 Mn |
| Sep 30, 2025 | 100.27 Mn |
| Jun 30, 2025 | 99.49 Mn |
| Mar 31, 2025 | 112.81 Mn |
| Dec 31, 2024 | 107.25 Mn |
| Sep 30, 2024 | 91.68 Mn |
| Jun 30, 2024 | 78.30 Mn |
| Mar 31, 2024 | 76.91 Mn |
| Dec 31, 2023 | 79.64 Mn |
| Sep 30, 2023 | 81.31 Mn |
| Jun 30, 2023 | 81.85 Mn |
| Mar 31, 2023 | 80.87 Mn |
| Dec 31, 2022 | 81.73 Mn |
| Sep 30, 2022 | 84.56 Mn |
| Jun 30, 2022 | 82.89 Mn |
| Mar 31, 2022 | 86.54 Mn |
| Dec 31, 2021 | 75.11 Mn |
| Sep 30, 2021 | 71.78 Mn |